WAYFINDER GENETICS, LLC

Wayfinder Genetics, LLC specializes in rapid infectious disease detection technologies for military and defense applications, leveraging cutting-edge molecular diagnostics and quorum sensing biology to enable real-time battlefield diagnostics. Their core capabilities center on the design and development of point-of-care biosensors that identify pathogen-associated signaling molecules, allowing for early, non-invasive infection detection in austere environments. The company applies advanced bioanalytical techniques to translate fundamental microbiological research into field-deployable tools that enhance warfighter survivability and operational continuity. Technical expertise includes molecular sensing platforms, signal transduction analysis, microfluidic integration, and rapid assay development tailored for high-stress, low-resource settings. Their differentiation lies in the novel application of bacterial communication systems—quorum sensing molecules—as biomarkers for infection, a paradigm shift from traditional culture- or PCR-based methods. Wayfinder Genetics has established a focused relationship with the Department of Defense, delivering research and development solutions aimed at enhancing combat medical readiness. Their work supports military medical innovation programs through Phase I STTR contracts and direct R&D initiatives focused on battlefield diagnostics, demonstrating alignment with DoD priorities in next-generation combat casualty care. The company operates primarily under NAICS 541715, conducting life sciences research that bridges microbiology, bioengineering, and clinical diagnostics. Their vertical specialization is in translational infectious disease detection, positioning them as a niche innovator in defense-relevant biotechnology outside of conventional biotech domains. Wayfinder Genetics is a Service-Disabled Veteran-Owned Small Business headquartered in Whitinsville, Massachusetts. Their 2L entity structure reflects a lean, agile R&D model optimized for federal innovation funding, with certifications that enhance eligibility for targeted defense and science procurement programs.